CJC-1295 & Ipamorelin Dosage Guide
Complete guide to CJC-1295 & Ipamorelin dosing protocols, administration methods, and safety considerations for research purposes.
Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.
Recommended Dosage
CJC-1295 (no DAC/Mod GRF 1-29): 100-300mcg combined with Ipamorelin 200-300mcg, administered 1-3 times daily. Best results when administered fasted or before sleep.
Administration Method
Subcutaneous injection. Often administered before bedtime to enhance natural nighttime GH release, or in the morning fasted. The combination is typically pre-mixed or injected simultaneously.
Side Effects to Monitor
Water retention, tingling in extremities, mild headaches, lightheadedness, or increased hunger. Generally well-tolerated with minimal effect on cortisol or prolactin.
Safety Considerations & Risks
Long-term effects on pituitary function not fully understood. May affect blood glucose levels. Not approved for human use.